EN
HI

PANACEA BIOTEC Share price

PANACEABIO

HealthcareMid

511.05

8.30 (-1.60%)
NSE
BSE
Last updated on 6 May, 2025 | 12:41 IST
BUYSELL
Today's High

504.05

Today's Low

526.80

52 Week Low

581.90

52 Week High

581.90

The current prices are delayed, login to your account for live prices

Panacea Biotec Chart

PANACEA BIOTEC Share Key Metrics

Volume
1.24 L
Market Cap
3181.06 CR
LTQ@LTP
1@511.05
ATP
516.7
Var Margin
2806
Circuit Range
493.4-545.3
Delivery %
45.45
Value
6.39 CR
ASM/GSM
No
Market Lot
1

PANACEA BIOTEC Futures & Options

Data Not Found

PANACEA BIOTEC Corporate Actions

DateAgenda
2025-02-14Quarterly Results
DateEvent TypeAgenda
2025-02-14Board MeetingQuarterly Results

PANACEA BIOTEC News

Panacea Biotec shares rally 5% as co gets UNICEF supply order worth Rs 127 crore

Dec 26 2024 09:56:53

Panacea Biotec shares in focus as co gets UNICEF supply order worth Rs 127 crore

Dec 26 2024 09:31:53
Read More

About PANACEA BIOTEC

NSE : 4055  
BSE : 531349  
ISIN : INE922B01023  

Panacea Biotec Ltd. was incorporated as a private limited company in the name and style of Panacea Drugs Private Ltd. on 2nd February 1984. Subsequently the Company became deemed Public limited Company u/s 43A(1 A) of the Companies Act 1956 w.e.f. 30.6.93. The shareholders of the Company in Extra Ordinary General Meeting passed a special resolution on 26.7.93 for deleting the Registration Clause from Articles of Association of the Company u/s 3(1) (iii) of the Companies Act 1956 and as such Company became full fledge public limited Company within the meaning of Section 3 (1) iv) of the Companies Act. Thereafterer the name of the Company hanged to Panacea Biotec Limited on 7th September 1993.The Company has been promoted by Mr. Sosh Kumar Jain who is a pharmacist having about 40 years of experience in the pharmaceutical industry.The Company started its operations in the year 1985 by identifying and importing a group of life saving drugs which were not available in the country for acute diseases like cancer haemophilia cardiac diseases infertility etc. These drugs were imported at an economical price andmade available through a distribution network of stockists all over the country. Having made a significant presence in the markat and after understanding the scope of the product and the latest trend in the medical field the Company made plans to set up its own manufacturing unit in 1989 and thereafter established a marketing team with an already existing distribution network for promotion of ethicalformulations.The promotors of the Company also happened to be the artners in another group company - Radicura Pharma engaged in he line of business of vaccines. Having established its marketing strength in both the group companies i.e. Vaccine Division as well as Pharma marketing the Company decided to make a single entity by merging both the unitsin the year 1992. The company is now utilising the strength of the products and marketing team of both the unit for better performance in the coming years. The Company continue to manufacture the Vaccines under Radicura Pharma with the after now functioning as a division of the Company.The Company started its Export promotion in 1991-92 when product registration in different countries was initiated. During 1993-94 the Comapny exported products worth Rs. 1.00 Crore.Presently the Company is engaged in 4 product lines of Pharmaceuticals. These are :- a) Vaccines b) Biologicals c) formulations d) Natural ProductsThe ethical formulations being promoted is on an all India basis. The Company has a significant presence in different therapeutic Groups. The company has a well established marketing network with dealers spread all over the country. The Company now proposes to expand the capacity of Vaccines Division along with an expansion in the capacities of capsules and suspensions.The company has achieved consistent improvement in rating terms of retail chemist sales out of top 200 Companies in India (Source: ORG Retail Sales Rating) out of companies promoting products ethically.Year March 1993 March 1994Rating 187 153Out of 200 200

PANACEA BIOTEC Management

NamePosition
Dr. Rajesh Jain Chairman & Managing Director
Mr. Sandeep Jain Joint Managing Director
Mr. Ankesh Jain Whole Time Director
Mrs. Ambika Sharma Non Executive Director
Mr. N N Khamitkar Non Executive Director
Read More

PANACEA BIOTEC FAQs

The Buying Price of PANACEA BIOTEC share is 121.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy PANACEA BIOTEC share to your Choice trading account, or open a Choice Demat account, then add funds, search the company name, select your order type, and place your trade.

The Price-to-earnings (P/E) ratio of PANACEA BIOTEC shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio PANACEA BIOTEC shares is 9.76. Useful to assess the stock's value relative to its book value.

To assess PANACEA BIOTEC’s valuation compare Sector P/E, P/B which are 34.16 & 4.86 with sector averages, along with growth rates and financial metrics.

The Market Cap of PANACEA BIOTEC is 3181.06 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of PANACEA BIOTEC share price is 581.90 & 112.35. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.